Epic Sciences logo — Epic Sciences, Inc. is developing novel diagnostics to perso...

Epic Sciences

Epic Sciences, Inc. is developing novel diagnostics to personalize and advance the treatment and management of cancer.

Founded 2008 United States San Diego, United States 89 employees Series G Total: $219.50M Biotechnology, Health Care

General Information

Company Name Epic Sciences
Founded Year 2008
Location United States San Diego, United States
Founders / Decision Makers
Team member
Employees 89
Industries Biotechnology, Health Care
Funding Stage Series G
Social

BounceWatch is an independent company data service, not affiliated with Epic Sciences. To contact Epic Sciences, visit epicsciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Epic Sciences

Epic Sciences, Inc. is developing novel diagnostics to personalize and advance the treatment and management of cancer. Their mission is to enable the rapid and non-invasive detection of genetic and molecular changes in cancer throughout a patient’s journey. Founded in 2008, the company focuses on identifying and characterizing rare cells, including circulating tumor cells (CTCs). Epic Sciences partners with leading pharmaceutical companies and major cancer centers worldwide, aiming to commercialize their technology to increase the success rate of cancer drugs in clinical trials. Their recent $24.00M Series G investment on 14 April 2023 was led by Domain Associates, Arsenal Capital Partners, Blue Ox Healthcare Partners, LabCorp, and Deerfield Capital Management. Epic Sciences' goal is to improve patient outcomes by providing physicians with real-time information to guide treatment choices. For more information, contact them at [email protected].

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Series G $24.00M 5
Domain Associates, Arsenal Capital Partners +3
14 Apr 2023
Series F $43.00M 4
Arsenal Capital Partners, Blue Ox Healthcare Partners +2
01 Jun 2022
Series E $52.00M 9
Domain Associates, Alexandria Venture Investments +7
12 Sep 2018
Series D $40.00M 9
Domain Associates, Sabby Capital +7
28 Apr 2017
Debt Financing $15.00M 1
Silicon Valley Bank
01 Jun 2015
Series C $30.00M 5
Domain Associates, Arcus Ventures +3
30 Jul 2014
Series B $13.00M 3
Domain Associates, Roche Venture Fund +1
13 Nov 2012
Series A $2.50M 1
Venrock
30 Jun 2009

Epic Sciences Alternatives & Competitors

Epic Sciences vs
HiberCell
HiberCell United States

Developing Novel Therapeutics to Prevent Cancer Relapse and Metastasis

25 employees
Biotechnology, Health Care
Epic Sciences vs
PrognosDx Health
PrognosDx Health United States

Pioneering the future of cancer diagnostics through advanced epigenetic testing and innovative histo...

Debt Financing
2-10 employees
Biotechnology, Health Care
Epic Sciences vs
TellBio, Inc.
TellBio, Inc. United States

Freeing patients from the tyranny of cancer™

Series A
5 employees
Biotechnology, Health Care

FAQ About Epic Sciences

Epic Sciences, Inc. is developing novel diagnostics to personalize and advance the treatment and management of cancer.
Epic Sciences was founded in 2008.
Epic Sciences is headquartered in San Diego, United States.
Epic Sciences operates in Biotechnology and Health Care.
Epic Sciences has approximately 89 employees.
Epic Sciences has completed 8 funding rounds, raising a total of $219.50M. The latest funding stage is Series G.
Top alternatives and competitors to Epic Sciences include HiberCell, PrognosDx Health, TellBio, Inc., On-Q-ity, Quince Therapeutics SpA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Epic Sciences and HiberCell are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Epic Sciences, https://bouncewatch.com/company/epic-sciences, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes